Ovid Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

DB:1OT Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
18 Mar 24Buy€46,325Jeremy LevinIndividual18,248€2.54

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 1OT?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders3,701,6555.21%
Public Companies7,531,99610.6%
Hedge Funds13,286,56018.7%
General Public20,689,14229.1%
Institutions25,800,51336.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 68.14% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.6%
Takeda Pharmaceutical Company Limited
7,531,996€7.2m0%no data
7.49%
Rubric Capital Management LP
5,315,969€5.1m0%0.1%
6.08%
BlackRock, Inc.
4,314,437€4.1m8.07%no data
5.8%
Madison Avenue Partners, LP
4,116,773€4.0m0.85%0.31%
5.43%
BVF Partners L.P.
3,853,818€3.7m0%0.13%
5.14%
Jeremy Levin
3,652,196€3.5m0%no data
4.43%
The Vanguard Group, Inc.
3,142,439€3.0m1.72%no data
4.01%
Artal Group S.A.
2,850,000€2.7m14%0.09%
2.6%
Acadian Asset Management LLC
1,847,334€1.8m11%no data
2.15%
Kennedy Capital Management LLC
1,527,985€1.5m2.65%0.03%
1.97%
Driehaus Capital Management LLC
1,400,191€1.3m0%0.01%
1.92%
State Street Global Advisors, Inc.
1,361,455€1.3m0.52%no data
1.86%
Geode Capital Management, LLC
1,317,330€1.3m1.14%no data
1.85%
JP Morgan Asset Management
1,315,585€1.3m-1%no data
1.09%
TLS Advisors LLC
771,531€740.7k-31.4%1.82%
1.03%
Prosight Management, LP
729,208€700.1k-32.2%0.2%
1.01%
Wells Fargo & Company, Securities and Brokerage Investments
717,046€688.4k-0.79%no data
0.88%
UBS O'Connor LLC
628,290€603.2k118%0.06%
0.68%
Northern Trust Global Investments
480,225€461.0k3.16%no data
0.64%
Bridgeway Capital Management, LLC
454,880€436.7k-7.19%0.01%
0.37%
GSA Capital Partners LLP
260,509€250.1k118%0.02%
0.35%
Ariad Asset Management GmbH
250,000€240.0k0%0.19%
0.31%
BNP Paribas Arbitrage Sa, Asset Management Arm
220,401€211.6k4,130%no data
0.23%
BNY Asset Management
165,763€159.1k-24%no data
0.23%
Morgan Stanley, Investment Banking and Brokerage Investments
163,614€157.1k147%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 00:07
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Ovid Therapeutics Inc. is covered by 14 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kalpit PatelB. Riley Securities, Inc.
Thomas ShraderBTIG
Charles DuncanCantor Fitzgerald & Co.